We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 265

Noose or loose? Mind the ensnarement trap door

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 30 2011

Just how tight is the noose around that patent infringer?

False marking update: the beginning of the end or the end of the beginning?

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 29 2011

In late 2009, the Federal Circuit’s unexpected opinion in Forest Group, Inc. v. Bon Tool Co. spawned a flood of false marking cases

House bill would impose litigation costs on losing non-practicing entities

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 7 2013

U.S. Reps. Peter DeFazio (D-Ore.) and Jason Chaffetz (R-Utah) have introduced legislation (H.R. 845) that would create a "loser pays" system in

What's behind the curtain? Exposing the case up front with Twombly and Iqbal

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 4 2010

For decades, litigants essentially had a free ride, comforting themselves that "notice pleading" required only "a short and plain statement of the claim."

Biotech trade group seeks USDA involvement in gene patents lawsuit

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 21 2010

The Biotechnology Industry Organization (BIO) has asked U.S. Department of Agriculture (USDA) Secretary Tom Vilsack to urge the Department of Justice, which is considering the federal government's position in litigation about patent protection for isolated DNA sequences, to "strongly defend the patentability of such basic biotech inventions."

Don’t get spooked by means-plus-function ‘equivalents’

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 27 2010

Patent attorneys often shudder when it comes to "means-plus-function" claims and the related term equivalents

Pharma merger activity attributed to “patent cliff”

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 18 2010

Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies

Administration budget-cut plan includes reducing data exclusivity for biologic drugs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 24 2011

Among other provisions included in President Barack Obama’s (D) $3.7 trillion budget proposal is a plan to give biotech drugs seven years of market exclusivity rather than the 12 years already in effect

DOJ seeks earliest calendaring before Federal Circuit in Myriad Genetics

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 24 2011

Acting Solicitor General Neal Katyal has requested an April 4, 2011, oral argument date in a case before the Federal Circuit Court of Appeals asking whether and to what extent genetic discoveries may be patented

WIPO announces increase in filings under international patent treaty

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • February 24 2011

The World Intellectual Property Organization (WIPO) has released data on international patent filings under the Patent Cooperation Treaty showing a nearly 5 percent increase from 2009 to 2010

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy